Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raimar Kern

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
BMC Neurology|June 19, 2015
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practiceTjalf Ziemssen, Raimar Kern, Christian Cornelissen
BMC Neurology|August 10, 2016
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimodTjalf Ziemssen, Raimar Kern, Christian Cornelissen
BMC Neurology|August 4, 2016
Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approachTjalf Ziemssen, Raimar Kern, Katja Thomas
Frontiers in Neurology|July 3, 2020
Data Collection in Multiple Sclerosis: The MSDS ApproachTjalf Ziemssen, Raimar Kern, Isabel Voigt, et al.
Patient Preference and Adherence|February 26, 2024
Preferences, Adherence, and Satisfaction: Three Years of Treatment Experiences of People with Multiple SclerosisOlaf Hoffmann, Friedemann Paul, Rocco Haase, et al.
Interactive Journal of Medical Research|January 10, 2016
Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation SystemRaimar Kern, Rocco Haase, Judith Christina Eisele, et al.
Expert Opinion on Drug Safety|February 14, 2018
Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approachRocco Haase, Maria Wunderlich, Anja Dillenseger, et al.
Deutsche Medizinische Wochenschrift (1946)|September 14, 2017
[Implementation of the National Guidelines for the treatment of Diabetes mellitus type 2 in secondary diabetes centers]Lydia Marahrens, Daniel Röck, Tjalf Ziemssen, et al.
BMC Ophthalmology|August 11, 2017
Patients' preferences for involvement in the decision-making process for treating diabetic retinopathyLydia Marahrens, Raimar Kern, Tjalf Ziemssen, et al.
BMC Neurology|July 20, 2016
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)Tjalf Ziemssen, Ulrich Engelmann, Sigbert Jahn, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
BMC Neurology|June 19, 2015
The PANGAEA study design - a prospective, multicenter, non-interventional, long-term study on fingolimod for the treatment of multiple sclerosis in daily practiceTjalf Ziemssen, Raimar Kern, Christian Cornelissen
BMC Neurology|August 10, 2016
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimodTjalf Ziemssen, Raimar Kern, Christian Cornelissen
BMC Neurology|August 4, 2016
Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approachTjalf Ziemssen, Raimar Kern, Katja Thomas
Frontiers in Neurology|July 3, 2020
Data Collection in Multiple Sclerosis: The MSDS ApproachTjalf Ziemssen, Raimar Kern, Isabel Voigt, et al.
Patient Preference and Adherence|February 26, 2024
Preferences, Adherence, and Satisfaction: Three Years of Treatment Experiences of People with Multiple SclerosisOlaf Hoffmann, Friedemann Paul, Rocco Haase, et al.
Interactive Journal of Medical Research|January 10, 2016
Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation SystemRaimar Kern, Rocco Haase, Judith Christina Eisele, et al.
Expert Opinion on Drug Safety|February 14, 2018
Improving multiple sclerosis management and collecting safety information in the real world: the MSDS3D software approachRocco Haase, Maria Wunderlich, Anja Dillenseger, et al.
Deutsche Medizinische Wochenschrift (1946)|September 14, 2017
[Implementation of the National Guidelines for the treatment of Diabetes mellitus type 2 in secondary diabetes centers]Lydia Marahrens, Daniel Röck, Tjalf Ziemssen, et al.
BMC Ophthalmology|August 11, 2017
Patients' preferences for involvement in the decision-making process for treating diabetic retinopathyLydia Marahrens, Raimar Kern, Tjalf Ziemssen, et al.
BMC Neurology|July 20, 2016
Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS)Tjalf Ziemssen, Ulrich Engelmann, Sigbert Jahn, et al.
Pageof 2